COVID-19, thromboembolic risk and thromboprophylaxis: learning lessons from the bedside, awaiting evidence
- PMID: 32453688
- PMCID: PMC7250684
- DOI: 10.2450/2020.0113-20
COVID-19, thromboembolic risk and thromboprophylaxis: learning lessons from the bedside, awaiting evidence
Conflict of interest statement
Comment on
-
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy.J Thromb Haemost. 2020 May;18(5):1094-1099. doi: 10.1111/jth.14817. Epub 2020 Apr 27. J Thromb Haemost. 2020. PMID: 32220112 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources